PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

PDE4

PDE4 inhibitors, dermatology and respiratory access, payer criteria, and class positioning.

2 articles·Lives underPricing & Access Specialty·Last updated 2026-07-15

Pricing & Access· July 15, 2026 · 21 min read

COPD Access Landscape 2026: Inhaled Triple Therapy, Dupilumab, and Ensifentrine

By Ran Chen#Respiratory #Payer Criteria #Specialty Pharmacy

Pricing & Access· July 15, 2026 · 19 min read

IPF Access Landscape 2026: Jascayd, Ofev Generic entry, and Pirfenidone Pricing

By Ran Chen#Respiratory #Payer Criteria #Specialty Pharmacy